MoonLake Immunotherapeutics (MLTX) Sector
Health Care

(Current) $10.68
-0.02 (-0.19%) Open Price: 10.63

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients

(10/13/26) $10.63
(10/13/26) $10.70
(10/13/26) (Qty.)1,075,173
(10/13/26) $10.55
(10/13/26) $10.84
(10/04/26) $10.00
(06/21/26) $23.29
Stocktwits
LetsEncrypt SSL Secure Stripe Payment Processing